114 related articles for article (PubMed ID: 35427076)
1. Expression of concern: Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway.
Fisher L
RSC Adv; 2022 Feb; 12(8):4777. PubMed ID: 35427076
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway.
Yang Z; Chen W
RSC Adv; 2019 Jul; 9(37):21381-21390. PubMed ID: 35521355
[TBL] [Abstract][Full Text] [Related]
3. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
4. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
Ellis BC; Graham LD; Molloy PL
Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
Tang Q; Zheng X; Zhang J
Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
[TBL] [Abstract][Full Text] [Related]
6. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
7. Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma.
Zhao Z; Liu M; Long W; Yuan J; Li H; Zhang C; Tang G; Jiang W; Yuan X; Wu M; Liu Q
Cancer Cell Int; 2021 Aug; 21(1):456. PubMed ID: 34454479
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
Du DX; Lian DB; Amin BH; Yan W
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CRNDE regulates cell proliferation, migration, invasion, epithelial-mesenchymal transition and apoptosis in oral squamous cell carcinoma.
Dai J; Mu JW; Mu H
Oncol Lett; 2019 Mar; 17(3):3330-3340. PubMed ID: 30867767
[TBL] [Abstract][Full Text] [Related]
10. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression.
Li X; Rui B; Cao Y; Gong X; Li H
Oncol Lett; 2020 Mar; 19(3):2035-2042. PubMed ID: 32194700
[TBL] [Abstract][Full Text] [Related]
12. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
[TBL] [Abstract][Full Text] [Related]
14. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway.
Song Q; Zhang H; He J; Kong H; Tao R; Huang Y; Yu H; Zhang Z; Huang Z; Wei L; Liu C; Wang L; Ning Q; Huang J
Ther Adv Med Oncol; 2020; 12():1758835920937890. PubMed ID: 32922520
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CRNDE may be associated with poor prognosis by promoting proliferation and inhibiting apoptosis of cervical cancer cells through targeting PI3K/AKT.
Yang HY; Huang CP; Cao MM; Wang YF; Liu Y
Neoplasma; 2018 Nov; 65(6):872-880. PubMed ID: 30334449
[TBL] [Abstract][Full Text] [Related]
18. CRNDE promotes cell tongue squamous cell carcinoma cell growth and invasion through suppressing miR-384.
Ren Y; He W; Chen W; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Chai J; Sun M
J Cell Biochem; 2019 Jan; 120(1):155-163. PubMed ID: 30242873
[TBL] [Abstract][Full Text] [Related]
19. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ADAMTS9-AS1 exacerbates cell proliferation, migration, and invasion via triggering of the PI3K/AKT/mTOR pathway in hepatocellular carcinoma cells.
Zhang Z; Li H; Hu Y; Wang F
Am J Transl Res; 2020; 12(9):5696-5707. PubMed ID: 33042449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]